Clinical Research Programs
NJU physicians are engaged in a variety of clinical research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases. We are proud of the leadership role our doctors take in helping to prove the safety and efficacy of new treatments, and the opportunity it gives us to make those options available to our patients. Those potential advantages, however, are always considered in the context of the overall health and well-being of our patients.
Our clinical research department has a dedicated research staff who will assist you through your entire journey. Our state-of-the-art facilities offer a locked storage area for all trial-specific documentation and Investigational Product (IP), -70°F freezers to store specimens and IP, electrocardiogram (ECG) machines, refrigerated centrifuges for precise temperature management and sample protection, and pharmacokinetics (PK) capabilities.
If you think you may be eligible for and interested in participating in a clinical research program, your NJU urologist will discuss the potential benefits and risks with you so that you and your family can make an informed decision.
CLINICAL TRIALS | PROSTATE CANCER IMMUNOTHERAPY TRIALS
You may be eligible for New Jersey Urology’s immunotherapy clinical trials now available at our Saddle Brook and West Orange, New Jersey Cancer Treatment Centers.
What is Immunotherapy?
Immunotherapy teaches your body to spot and destroy cancer cells, and may help your immune system long after your treatment ends.
Types of Immunotherapy
Certain types of immunotherapy attack cancer while sparing healthy cells or slow its spread to other parts of the body.
Register now to see if you qualify or call 201-881-2000.
VIDEO SERIES | CLINICAL RESEARCH
New Jersey Urology (NJU) physicians are engaged in a variety of research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases.
NJU’s Senior Vice President of Clinical Research, Derek Grimes, is interviewed by UroGPO to discuss what makes clinical research a success in the field of urology.
New Jersey Urology has extensive experience in conducting Phase 1b – IV trials in the following urological therapeutic areas:
Our Clinical Research Department works with a variety of sponsor companies and contract research organizations, including:
- Advanced Biologics
- Barr-Laboratories, Inc.
- Boehringer Ingelheim Pharmaceuticals
- Glaxo Smith Kline
- GTx Inc.
- Kendle International, Inc.
- MDS Pharma Services
- Pallisades Pharmaceuticals
- TAP Pharmaceutical Products, Inc.
- Upjohn Company
If you’ve been diagnosed with enlarged prostate, or Benign Prostatic Hyperplasia (BPH), you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.
We are currently recruiting patients for NJU’s Prostate Cancer Immunotherapy Clinical Trials. To see if you may qualify, sign up at www.prostateclinicaltrials.com or call 201.881.1000.
If you’ve been diagnosed with urologic cancer, such as bladder, kidney or prostate cancer, you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.
If you’ve been diagnosed with urinary incontinence, or Overactive Bladder (OAB), you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.
To make an appointment with an NJU physician with expertise in Clinical Research, please call one of the phone numbers listed below.